CAS 1630086-20-2

Kira8

CAS : 1630086-20-2

Kira8 (AMG-18) is a mono-selective IRE1α inhibitor that allosterically attenuates IRE1α RNase activity (IC50: 5.9 nM).

Formule : C₃₁H₂₉ClN₆O₃S

Degré de pureté : 98.07%

Couleur et forme : Solid

Masse moléculaire : 601.12

Ref: TM-T11762L

AmgenIRE1αInhibitor

CAS : 1630086-20-2

Formule : C₃₁H₂₉ClN₆O₃S

Degré de pureté : 97%

Couleur et forme : Solid

Masse moléculaire : 601.1184

Ref: IN-DA01E2K5

(S)-2-Chloro-N-(6-Methyl-5-((3-(2-(Piperidin-3-Ylamino)Pyrimidin-4-Yl)Pyridin-2-Yl)Oxy)Naphthalen-1-Yl)Benzenesulfonamide

CAS : 1630086-20-2

(S)-2-Chloro-N-(6-Methyl-5-((3-(2-(Piperidin-3-Ylamino)Pyrimidin-4-Yl)Pyridin-2-Yl)Oxy)Naphthalen-1-Yl)Benzenesulfonamide

Degré de pureté : 97%

Masse moléculaire : 601.12g/mol

Ref: 54-OR1024167

Kira8

CAS : 1630086-20-2

Kira8

Degré de pureté : ≥98%

Masse moléculaire : 601.12g/mol

Ref: 54-BUP05586

Amgen IRE1α Inhibitor

Produit contrôlé

CAS : 1630086-20-2

Formule : C₃₁H₂₉ClN₆O₃S

Couleur et forme : Neat

Masse moléculaire : 405.38

Ref: TR-A576530

Amgen IRE1± Inhibitor

CAS : 1630086-20-2

Amgen IRE1± Inhibitor is a biological sample that can be obtained from humans or animals. It has an inhibitory effect on the enzyme IRE1 and is used to investigate the role of this enzyme in heart function, inflammatory diseases, cancer and diabetic neuropathy. Amgen IRE1± Inhibitor may also have a role in the transfer reactions of proteins. The homologous protein for this drug is found in humans and other mammals. This drug has a signal peptide that targets it to the endoplasmic reticulum, where it inhibits serine protease activity by binding to Grp78. It is also known to regulate protein synthesis by inhibiting cycle analysis.

Formule : C₃₁H₂₉ClN₆O₃S

Degré de pureté : Min. 95%

Masse moléculaire : 601.12 g/mol

Ref: 3D-FQC08620